课题基金 / 基金详情

项目摘要

项目成果

Ali I. Fattom的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The NIAID/DAIT Adjuvant Development Program supports the development of new candidate vaccine adjuvants through immunological characterization studies and lead compound optimization, up to and including IND-enabling studies, all towards licensure for human use. Adjuvants will be studied with currently licensed or new investigational vaccines to protect against infection by NIAID emerging and re-emerging infectious disease pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10884987
  • 项目类别:
  • 资助金额:
    $7.93万
  • 财政年份:
    2020
  • 负责人:
    Ali I. Fattom
  • 依托单位:
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10018153
  • 项目类别:
  • 资助金额:
    $29.99万
  • 财政年份:
    2019
  • 负责人:
    Ali I. Fattom
  • 依托单位:
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10250294
  • 项目类别:
  • 资助金额:
    $291.65万
  • 财政年份:
    2019
  • 负责人:
    Ali I. Fattom
  • 依托单位:
Pre-Clinical Development of a Intranasal Bivalent gD2/gB2 HSV-2 Mucosal Vaccine
  • 批准号:
    10076038
  • 项目类别:
  • 资助金额:
    $99.87万
  • 财政年份:
    2017
  • 负责人:
    Ali I. Fattom
  • 依托单位:
海外基金